Harini Nagaraj

Ms. Harini Nagaraj

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2023 in ACS Nano
Verified
Journal Article
Closed access
TJTaewon Jeon
Taewon Jeon
DLDavid C. Luther
David C. Luther
RGRitabrita Goswami
Ritabrita Goswami
CBCharlotte Bell
Charlotte Bell
HNHarini Nagaraj
Harini Nagaraj
Vincent M. RotelloVincent M. Rotello
Vincent M. Rotello

19 April 2021 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
DLDavid C. Luther
David C. Luther
TJTaewon Jeon
Taewon Jeon
RGRitabrita Goswami
Ritabrita Goswami
HNHarini Nagaraj
Harini Nagaraj
DKDongkap Kim
Dongkap Kim
Vincent M. RotelloVincent M. Rotello
Vincent M. Rotello

18 April 2022 in ACS Nano
Verified
Journal Article
Closed access
DLDavid C. Luther
David C. Luther
YLYi-Wei Lee
Yi-Wei Lee
HNHarini Nagaraj
Harini Nagaraj
VCVincent Clark
Vincent Clark
TJTaewon Jeon
Taewon Jeon
Vincent M. RotelloVincent M. Rotello
Vincent M. Rotello

26 September 2024 in Nanomaterials
Verified
Journal Article
Open access
PDF file
RGRitabrita Goswami
Ritabrita Goswami
ANAhmed Nabawy
Ahmed Nabawy
Mingdi JiangMingdi Jiang
Mingdi Jiang
YCYagiz anil Cicek
Yagiz anil Cicek
MHMuhammad Aamir Hassan
Muhammad Aamir Hassan
Vincent M. RotelloVincent M. Rotello
Vincent M. Rotello
Macrophages are multifunctional immune cells essential for both innate and adaptive immune responses. Tumor-associated macrophages (TAMs) often adopt a tumor-promoting M2-like phenotype, aiding tumor progression and immune evasion. Reprogramming TAMs to a tumoricidal M1-like phenotype is an emerging target for cancer immunotherapy. Resiquimod, a TLR7/8 agonist, can repolarize macrophages from the M2- to M1-like phenotype but is limited by poor solubility. We developed a gelatin nanoemulsion for the loading and delivery of resiquimod, utilizing eugenol oil as the liquid phase and riboflavin-crosslinked gelatin as a scaffold. These nanoemulsions showed high stability, low toxicity, and effective macrophage repolarization, significantly enhancing pro-inflammatory markers and anticancer activity in co-culture models.

8 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RGRitabrita Goswami
Ritabrita Goswami
VLVictor Lehot
Victor Lehot
YCYagiz anil Cicek
Yagiz anil Cicek
HNHarini Nagaraj
Harini Nagaraj
TJTaewon Jeon
Taewon Jeon
Vincent M. RotelloVincent M. Rotello
Vincent M. Rotello
Current intracellular protein delivery strategies face the challenge of endosomal entrapment and consequent degradation of protein cargo. Methods to efficiently deliver proteins directly to the cytosol have the potential to overcome this hurdle. Here, we report the use of a straightforward approach of protein modification using citraconic anhydride to impart an overall negative charge on the proteins, enabling them to assemble with positively charged nano vectors. This strategy uses anhydride-modified proteins to electrostatically form polymer–protein nanocomposites with a cationic guanidinium-functionalized polymer. These supramolecular self-assemblies demonstrated the efficient cytosolic delivery of modified proteins through a membrane fusion-like mechanism. This approach was validated on five cell lines and seven proteins as cargo. Retention of protein function was confirmed through efficient cell killing via the intracellular enzymatic activity of RNase A. This platform provides a versatile, straightforward, and single-step method of protein modification and efficient direct cytosolic protein delivery.

24 April 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
AGAarohi Gupta
Aarohi Gupta
MHMuhammad Aamir Hassan
Muhammad Aamir Hassan
WNWilliam Ndugire
William Ndugire
JPJungmi Park
Jungmi Park
SNSadaf Noor
Sadaf Noor
Vincent M. RotelloVincent M. Rotello
Vincent M. Rotello